Reduction of Topical Anesthetic Time for Subcutaneous Port Access Using Ultrasound

Connecticut Children's Medical Center

Status and phase: Completed; Phase 4

Conditions: Pain

Treatments: Device: SonoPrep

Study type: Interventional

Funder types: Other

Identifiers

NCT00126919

05-002

Details and patient eligibility

About

Children ages 3-17 who are undergoing port access receive both standard care, topical medicine for numbing (LMX4), and the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The procedures will be performed on 2 separate visits to the clinic. The child's pain with the access procedure is evaluated.

Enrollment: 40 estimated patients

Sex: All

Ages: 3 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children ages 3-17 with subcutaneous port

Exclusion criteria

• Emergent need for port access
• Allergy to lidocaine sodium lauryl sulfate

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)